MTOR and B-cell chronic lymphocytic leukemia: In conclusion, we propose that constitutively active known cell survival signaling pathways (BCR/AXL) in CLL cells may activate and maintain elevated levels of ROS via PI3K/AKT/mTOR axis (Fig. 6), a key regulator of mitochondrial oxygen consumption and oxidative capacity48.